Consolidated Cash Flow Statement € in Millions, $ in Millions	12 Months Ended
	Nov. 30, 2017 USD ($)	Nov. 30, 2016 USD ($)	Nov. 30, 2015 USD ($)
Operating activities
Net income	$ 477.4	$ 472.3	$ 401.6
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	125.2	108.7	105.9
Stock-based compensation	23.9	25.6	18.7
Brand name impairment included in special charges	0.0	0.0	9.6
Special charges and transaction and integration expenses	19.1	7.2	22.8
Amortization of inventory fair value adjustment associated with acquisition of RB Foods	20.9
Loss on sale of assets	1.3	1.5	0.6
Deferred income tax expense (benefit)	24.1	(40.0)	1.0
Income from unconsolidated operations	(33.9)	(36.1)	(36.7)
Increase (Decrease) in Financial Instruments Used in Operating Activities	(2.9)	0.0	0.0
Changes in operating assets and liabilities (net of effect of businesses acquired):
Trade accounts receivable	(13.0)	(21.0)	15.6
Inventories	44.6	(39.0)	(18.0)
Trade accounts payable	98.2	47.0	40.4
Other assets and liabilities	6.8	94.5	(2.4)
Dividends received from unconsolidated affiliates	23.6	37.4	30.9
Net cash provided by operating activities	815.3	658.1	590.0
Investing activities
Acquisitions of businesses (net of cash acquired)	(4,327.4)	(120.6)	(210.9)
Proceeds from Divestiture of Businesses, Net of Cash Divested	0.0	4.2	0.0
Capital expenditures	(182.4)	(153.8)	(128.4)
Proceeds from sale of property, plant and equipment	1.1	1.7	0.4
Proceeds from Life Insurance Policies	0.4	1.4	0.0
Net cash used in investing activities	(4,508.3)	(267.1)	(338.9)
Financing activities
Short-term borrowings, net	(134.6)	251.7	(127.4)
Long-term debt borrowings	3,989.6	6.0	247.0
Payments of Debt Issuance Costs	(7.7)	0.0	0.0
Long-term debt repayments	(272.7)	(202.0)	(1.6)
Proceeds from exercised stock options	29.5	36.8	38.4
Payments Related to Tax Withholding for Share-based Compensation	(5.8)	(3.5)	(5.3)
Payments of contingent consideration	(19.7)	0.0	0.0
Purchase of minority interest	1.2	0.0	0.0
Proceeds from Issuance of Common Stock	554.0	0.0	0.0
Common stock acquired by purchase	(137.8)	(242.7)	(145.8)
Dividends paid	(237.6)	(217.8)	(204.9)
Net cash provided by (used in) financing activities	3,756.0	(371.5)	(199.6)
Effect of exchange rate changes on cash and cash equivalents	5.4	(13.7)	(16.2)
Increase in cash and cash equivalents	68.4	5.8	35.3
Cash and cash equivalents at beginning of year	118.4	112.6	77.3
Cash and cash equivalents at end of year	186.8	118.4	$ 112.6
Payments of Stock Issuance Costs	$ 0.9
Payments to acquire interest in joint venture		$ (0.9)